Posted on

AmerisourceBergen

VN:F [1.9.11_1134]
Rating: 0 (from 0 votes)
As one of the nation’s largest drug distributors, Amerisource Bergen has been an obvious beneficiary of the booming generics business. But the company has quietly become a powerhouse in specialty drugs as well, from which it now generates about 20% of sales. For example, Amerisource commands more than half the community oncologist market, a business expected to see solid growth as baby boomers gray.No surprise, then, that Steve Collis, a 17-year company veteran — and the driving force behind Amerisource’s specialty drugs unit — was tapped to take over as CEO when longtime chief David Yost retires in July. —P.N.

source

VN:F [1.9.11_1134]
Customer Service
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Environmental Impact
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Corporate Welfare / Subsidies
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Employee Treatment
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Safety / Health
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Criminal Activity
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Outsourcing
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Community
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Sponsorships
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Politics
Rating: 0.0/5 (0 votes cast)

About corporatOCRACY

Corporatism meets Democracy; Wall Street meets Main Street.

Leave a Reply

Your email address will not be published. Required fields are marked *


*